期刊文献+

冠心病患者血清中cTnI和hs-CRP水平变化及意义 被引量:2

Changes and Significance of Serum Levels of cTnI and hs-CRP in Patients with Coronary Heart Disease
下载PDF
导出
摘要 目的:探讨冠心病患者血清中心肌肌钙蛋白O(cTnI)和超敏C反应蛋白(hs-CRP)水平变化及意义。方法:选取我院2009年5月至2013年4月收治的100例冠心病患者,将这些患者作为治疗组,另选取同期来我院进行健康体检的100例人员作为对照组,运用金标法检测两组人员的cTnI水平,运用胶体金法检测hs-CRP水平。结果:治疗组血清cTnI和和hs-CRP均明显比对照组高(P<0.01);治疗组患者cTnI和hs-CRP的阳性例数分别为56例和78例,阳性率分别为56%、78%,hsCRP的阳性率比cTnI高(P<0.05)。结论:冠心病患者血清中cTnI和hs-CRP水平显著升高,可以作为诊断冠心病的重要指标。 Objective:To investigate the changes and significance of serum troponin center ( cTnI) and high-sensitivity C-reactive protein ( hs-CRP ) levels of patients with coronary heart disease .Method:100 cases of coronary heart disease patients treated in our hospital from May 2009 to April 2013 were selected , they were regarded as the treatment group , and the other 100 cases of healthy people in the corresponding period in our hospital was selected as control group , The cTnI level was detected by gold standard method , and hs-CRP level was detected by colloidal gold method .Result:The serum cTnI and hs-CRP of the treat-ment group were significantly higher ( P 〈0.01) than those of the control group;cTnI and hs-CRP positive cases of patients in the treatment group were 56 cases and 78 cases, the positive rates were 56%and 78%, the positive rate of hs-CRP was higher than cTnI (P〈0.05).Conclusion:The cTnI and hs-CRP levels of coronary artery disease patients are significantly elevated , they can be used as an important indicator in the diagnosis of coronary heart disease .
出处 《河北医学》 CAS 2014年第7期1146-1147,共2页 Hebei Medicine
关键词 冠心病 CTNI hs—CRP 阳性率 Coronary heart disease cTnI hs-CRP Positive rate
  • 相关文献

参考文献5

二级参考文献28

  • 1万大国,张强,曾秋棠.冠心病患者介入治疗前后血清VEGF水平变化及意义[J].山东医药,2007,47(2):59-60. 被引量:9
  • 2徐荣丰,高大胜,王红雷.血清新蝶呤和单核细胞趋化蛋白-1在冠心病患者血清中的表达及意义[J].中国心血管病研究,2007,5(6):420-422. 被引量:13
  • 3Arefieva TI,Kukhtina NB,Antonova OA,et al. MCP-1 stimulated chemotaxis of monocytic and endothelial cells is dependent on activation of different signaling cascades [J]. Cytokine, 2005, 31 (6): 439-446.
  • 4Nishiyama K,Ogawa H,Yasue H,et al.Simultaneous elevation of the levels of circulating monocyte chemoattractant protein-1 and tissue factor in acute coronary syndromes[J].Jpn Circ J,1998,62(9):710-2.
  • 5Hristov M,Erl W, WeberPC.Endothelial progenitor cells:mobilization, differentiation,and homing[J].Arterioscler Thromb Vasc Biol,2003,23(7): 1185.
  • 6PradeepCR, SunilaES, KuttanG. Expression ofvascularendothelial growth factor (VEGF) andVEGF receptors in tumorangiogenesis and malignancies[J].lntegrCancerTher, 2005, 4(4): 315-321.
  • 7Vasa M,Fichtlscherer S,Adler K,et al.lncrease in circulatingendothelial progenitor cells by s tatin therapy in patients with s table coronary artery isease[J].Circulation,2001,103(24):2885.
  • 8Jialal I,Devaraj S.Low-density lipoprotein oxidation,antioxidants,and atherosclerosis:a clinical biochemistry perspective [J].Clin Chem,1996,42(2):498-506.
  • 9Steinberg D,Parthasarathy S,Carew T E,et al.Beyond cholesterol:modification of low-density lipoprotein that increase its atherogenicity [J].N Engl J Med,1989,320(4):915-924.
  • 10Cox D A,Cohen M L.Effects of oxidized low-density lipoprotein on vascular contraction and relaxation:clinical and pharmacological implications in atherosclerosis [J].Pharmacol Rev,1996,48(1):3-19.

共引文献142

同被引文献24

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部